Table of Contents
Notifications
Govt. of India issues Notifications time to time which are published by Department of Publication and are printed by the Government of India Printing Presses regularly.
We have provided some of the Gazette notifications relevant to the above said topic, Click below links for more information:
2020
S.O. 2451 (E) dt 20-07-2020 – Sec 26B – Exemption of sale license for sanitizers
2019
S.-O.-2607-E-dt.-19-07-2019-Section-26A-Banned-Colistin-and-its-formulations-for-food-producing-animals
S.-O. No.-180-E-to-259-E-dt.-11-01-2019-Section-26A-Banned-80-Fixed-dose-combinations
2017
GSR 144 (E) dated17-02-2017 – regulation on Oseltamivir phosphate & zanamivir
2016
GSR 705(E) to 1048(E) dt 10-03-2016 Sec 26A – 344 FDCs Banned – Notifications for banning various 344 FDCs
2015
GSR 558(E) Dt 17-07-2015 – Diclofenac Injection for Human use in single pack unit only
2011
G.S.R.-No.-752E-dt.-12-10-2011-Sec-26A-Ban-Letrozol
G.S.R.-No.-218E-dt.-18-03-2011-Sec-26A-Ban-Gatifloxacin-and-Tegaserol
G.S.R. No.-82E-dt.-10-02-2011-Sec-26A-Ban-Nimesulide-under-12-yrs-Sisapride-etc.
2010
G.S.R.-No.-910E-dt.-12-11-2010-Sec-26A-Ban-Rosiglitazone
2009
G.S.R-No.-677E-dt.-15-05-2009-Sec-26B-Sch-X-Oseltamivir-and-Zanamivir
2008
G.S.R-No.-499E-dt.-04-07-2008-Sec-26A-Ban-Diclofenac-for-animal-use
G.S.R-No.-290E-dt.-16-04-2008-Sec-26A-Ban-Salbutamol
2005
G.S.R-No.-510E-dt.-25-07-2005-Sec-26A-Ban-Valedioxib
1996
G.S.R.-No.-123-dt.-11-03-1996-Sec-26A-Ban-Phenylbutazone-etc.
1995
G.S.R No.-633E-dt.-13-09-1995-Sec-26A-Drugs-with-Ayurvedic-drugs
1992
G.S.R. 444(E) dt 30-04-1992 – Sec 26A – banned – Manufacturing of cosmetics containing tobacco banned
1983
G.S.R.-No.-578E-dt.-23-07-1983-Sec-26A-Banned-drugs
The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.
The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.
Follow and connect with us on Facebook and Linkedin
Go to main website, click here
Subscribe for daily free updates, click here
